Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia.
Nishio M, Endo T, Fujimoto K, Sato N, Sakai T, Obara M, Kumano K, Minauchi K, Koike T. Nishio M, et al. Among authors: koike t. Eur J Haematol. 2005 Dec;75(6):527-9. doi: 10.1111/j.1600-0609.2005.00552.x. Eur J Haematol. 2005. PMID: 16313268 No abstract available.
Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma.
Nishio M, Fujimoto K, Yamamoto S, Endo T, Sakai T, Obara M, Kumano K, Minauchi K, Yamaguchi K, Takeda Y, Sato N, Koizumi K, Mukai M, Koike T. Nishio M, et al. Among authors: koike t. Eur J Haematol. 2006 Sep;77(3):226-32. doi: 10.1111/j.1600-0609.2006.00693.x. Eur J Haematol. 2006. PMID: 16923109 Free article. Clinical Trial.
Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
Nishio M, Fujimoto K, Yamamoto S, Endo T, Sakai T, Obara M, Kumano K, Yamaguchi K, Takeda Y, Goto H, Sato N, Koizumi K, Mukai M, Koike T. Nishio M, et al. Among authors: koike t. Br J Haematol. 2007 May;137(4):349-54. doi: 10.1111/j.1365-2141.2007.06584.x. Br J Haematol. 2007. PMID: 17456057 Free article.
FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
Nishio M, Endo T, Fujimoto K, Yamamoto S, Obara M, Yamaguchi K, Takeda Y, Goto H, Kasahara I, Sato N, Koike T. Nishio M, et al. Among authors: koike t. Eur J Haematol. 2009 Feb;82(2):143-7. doi: 10.1111/j.1600-0609.2008.01174.x. Epub 2008 Nov 6. Eur J Haematol. 2009. PMID: 19018870
Non-Hodgkin lymphoma preceded by recalcitrant eczema.
Natsuga K, Abe R, Ujiie H, Shibaki A, Sawamura D, Nishio M, Fujimoto K, Koike T, Shimizu H. Natsuga K, et al. Among authors: koike t. Eur J Haematol. 2007 Oct;79(4):369-70. doi: 10.1111/j.1600-0609.2007.00897.x. Epub 2007 Jul 26. Eur J Haematol. 2007. PMID: 17655712 No abstract available.
2,579 results